Pharmacy Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

Pharmacy Podcast Network — Business
Pharmacy Podcast Network

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.

Join the home of the O.G. Pharmacy Podcast & discover our newest development: Evidence-based Podcasting, the first CME supplement in podcast form that’s truly peer-reviewed. The future of podcasting education for Providers is “Evidence-based Podcasting” (TM) and we’re building a peer-review board, reach out to us: Publisher @ Pharmacy Podcast dot com.

PPN is a division of RxPR, LLC. Copyright 2026

Latest Episodes:

Outcomes of Transparent PBMs V.S. the Status Quo | PBM Reform Podcast Series Mar 10, 2021

Show notes

What's the expected outcomes of a transparent PBM? How does a fiduciary driven pharmacy benefit management company compare to the 3 largest PBMs in the country processing more than 76% of all the prescriptions per year in the United States. The PBM market is dominated by three major players, who together handled about 76 percent of all prescription claims in 2018, according to Drug Channels Institute. A breakdown of PBM market share, by total equivalent prescription claims managed in 2018: Caremark (CVS Health) / Aetna: 30 percent Express Scripts: 23 percent OptumRx (UnitedHealth): 23 percent Humana Pharmacy Solutions: 7 percent MedImpact Healthcare Systems: 6 percent Prime Therapeutics: 6 percent All other PBMs + cash pay: 4 percent TrueScriptsmission is to build lasting relationships. They provide prescription benefit management expertise at a personal and customized level to ensure optimum value at the lowest possible cost. The TrueScripts team of nurses, pharmacists, legal experts, data scientists, and care specialists work together as one to bring prescription benefit expertise and a level of service that far exceeds that of any industry standard. Today's guest is Nathan Gabhart RPh Founder & CEO of TrueScripts. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Minimizing Your Student Loan Debt | Join Juno Loans Mar 10, 2021

Show notes

Chris Abkarians Co-Founder at Juno discusses strategies to minimize your student loan debt. Take advantage of this program: JoinJuno.loan Intro clip from CBS 8 San Diego On YouTube: Pressure mounting for President Biden to wipe out student loan debt About Juno: Juno’s founders, Nikhil Agarwal and Chris Abkarians were admitted to Harvard and then the dreaded tuition bill came. That summer, instead of taking expensive loans, they got 700 students from 10 schools together and negotiated lower rates for the entire group, saving their classmates ~$15K each. Juno came into existence from their desire to make this benefit available to all future generations of students. Today, Juno is able to get the lowest rate student loans for thousands. Learn more: JoinJuno.loan See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Lost in the Weeds | GameChangers Mar 09, 2021

Show notes

The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment. Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf CPE details for GameChangers Podcast March 2021 Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Plavix & the Case for Pharmacogenomic‪s‬ | PGX for Pharmacists Mar 08, 2021

Show notes

Becky Winslow PharmD, of PGX for Pharmacists podcast, joins Eric Geyer PharmD in this mash-up 'Pharmacy Podcast' hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction. Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics. Special insert from KHON2 News with Hawaii Attorney General Clare Connors held a news conference on Tuesday to discuss the million-dollar lawsuit against Bristol-Myers Squibb Co. and Sanofi. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Leaders in Pharmacy Prioritizing Public Health - Words of Wisdom from the New President of the American Pharmacist Association (APhA) Mar 08, 2021

Show notes

Dr. Sandra Leal is currently the Executive Vice President SinfoniaRx, A TRHC Solution and APhA President. She has published and presented her work in numerous national and international publications and venues including Peru, Saudi Arabia, and Japan. She has been recognized as the Good Government Pharmacist of the Year by the APhA for her advocacy work on pharmacist provider status. Dr. Leal received two Pinnacle Award from the APhA Foundation for her progressive practice innovations and received the ASHP Best Practice Award for her leading practice in diabetes management. Facebook/Twitter/Instagram Handle @slealrx LinkedIn Profile https://www.linkedin.com/in/slealrx National Center for Farmworker Health: www.ncfh.org Association of Clinicians for the Underserved: https://clinicians.org/ El Rio Health: www.elrio.org Tabula Rasa HealthCare: https://www.tabularasahealthcare.com/ American Pharmacists Association: www.pharmacist.com APhA Annual Meeting Link: https://apha2021.pharmacist.com//index.asp? See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacists Focused on LGBTQ Communities | Transforming a Nation Mar 05, 2021

Show notes

Our guests today are Michelle Sherman, RPh, who is a member of the Pharmacy Podcast Network & has a podcast called the "Conscious Pharmacist Podcast" & Jay Holloway PharmD, returning for a second time to the Pharmacy Podcat to discuss: References, from Pharmacy Today: https://www.pharmacytoday.org/article/S1042-0991(20)30876-8/fulltext Pharmacists Focused on LGBTQ Communities, the latest chapter of the "Transforming a Nation" podcast series. Pharmacists need to acquire foundational knowledge about key concepts and terminologies relevant to the LGBTQ population. To provide care consistent with cultural competence and humility, pharmacists must also be aware of the diversity between and within different segments of the LGBTQ community, and the intersectionality of multiple identities that shape a person’s life experiences. Furthermore, it is important to note that while various identities such as gender, sexual orientation, and gender identity intersect, one is not predictive of the other. For example, a person’s gender identity does not determine their sexual orientation and the biological sex designated at birth does not define their gender identity.11Sexual orientation is a person’s emotional, romantic, sexual attraction, or non-attraction to other people and is composed of three separate dimensions: behavior, identity, and desire. Some people may engage in same-sex sexual behavior but not identify as lesbian, gay, or bisexual. Similarly, a person may be sexually, romantically, or emotionally attracted to members of the same sex and choose not to be sexually active with same-sex partners. For research purposes, the terms “men who have sex with men” (MSM) and “women who have sex with women” (WSW) are often used to describe a person’s sexual behavior regardless of their identity. Sex refers to a set of biological attributes primarily related to physical and physiological features. The phrase “sex assigned at birth” (SAAB) or “designated sex at birth” (DSAB) is used to describe a person’s biological sex, most often, but not exclusively, based on the external appearance of genitalia at birth. Gender is a socially constructed concept used to characterize the behaviors, actions, and qualities of women and men or girls and boys. The critical flaw of an exclusive binary paradigm is that it does not account for the inherent diversity of human gender. A more expansive conceptualization of gender recognizes that each person possesses a wide range of characteristics that may or may not be consistent with the gender binary, represent a combination of male and female, or fall somewhere in between the two. Gender identity is a person’s inner sense of their gender. For some people, their gender identity may not be congruent with the one typically expected based on their SAAB/DSAB. They may describe themselves in a variety of ways including, but not limited to, transgender, male, female, gender fluid/genderqueer, nonbinary, agender, or as another gender. Decisions to change gender expression and/or physical appearance to be more consistent with their gender identity through medical (e.g., hormone replacement therapy), nonmedical (e.g., voice therapy, choosing an affirming name, etc.), and/or surgical options (e.g. gender affirmation/confirmation surgery) is wholly determined by the individual. The National LGBTQIA+ Health Education Center https://www.lgbtqiahealtheducation.org/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Business of Pharmacy TransPharmation | Mark Cuban Cost Plus Drugs Mar 05, 2021

Show notes

RxSafe & ApproRx have sponsored a gathering of 200+ pharmacy owners interested in learning more about a drug manufacturer interested in working directly with Pharmacy owners. Thanks to Bruce Kneeland and Todd Eury for hosting this LIVE presentation from March 2nd 2021. Today was the 12th anniversary of the Pharmacy Podcast Network. The 1st podcast about the profession of pharmacy launched episode 1 on March 2nd 2009. Today the PPN has 30+ hosts & is dedicated to the success of our pharmacists & pharmacy techs. Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company. Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result. Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs. In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make. The Pharmacy Podcast Network is the global leader in podcast content for the Business & Profession of Pharmacy. Since March 2009, the Pharmacy Podcast was the first audio blog for the pharmacy industry and has developed into a directory of over 25+ podcasts with different vertical informational themes. Collectively, over 2.5M downloads, more than 2,000+ episodes, and 30+ participating Pharmacists and Pharmacy Professionals hosting the podcasts. Learn more about your ad choices. Visit megaphone.fm/adchoices

The Janssen COVID-19 Vaccine- What Pharmacists Need to Know | Locked On Pharmacy Mar 04, 2021

Show notes

The Janssen COVID-19 Vaccine: What Pharmacists Need to Know On February 27, the FDA authorized the emergency use of a COVID-19 vaccine developed by the Johnson & Johnson subsidiary, Janssen Biotech – the third such vaccine to be so authorized. What do pharmacists need to know about this product? Our guests are Michael Hogue, President of APhA and a member of the CDC working group on COVID vaccines, and Stephan Foster, APhA’s liaison to the CDC’s Advisory Committee on Immunization Practices. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mark Garofoli, PharmD | PAIN POD Mar 02, 2021

Show notes

PAIN POD EPISODE 0 One of the most common definitions of pain describes pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage.” When we are exposed to something that causes pain, if able, we quickly or reflexively withdraw. The sensory feeling of pain is called nociception. What Does It Mean to Call Chronic Pain a Brain Disease? by Mark D. Sullivan https://www.jpain.org/article/S1526-5900(12)00560-3/pdf Multiple investigators have recently asked whether neuroimaging has shown that chronic pain is a brain disease. We review the clinical implications of seeing chronic pain as a brain disease. Abnormalities noted on imaging of peripheral structures have previously misled the clinical care of patients with chronic pain. We also cannot assume that the changes associated with chronic pain on neuroimaging are causal. When considering the significance of neuroimaging results, it is important to remember that ‘‘disease’’ is a concept that arises out of clinical medicine, not laboratory science. Our Host: Mark Garofoli, PharmD Clinical Assistant Professor WVU School of Pharmacy (Department of Clinical Pharmacy) WV School of Pharmacy curriculum education in areas of expertise such as pain management, substance-use disorder, medication therapy management, managed care, geriatric care, management, leadership, and experiential learning. Brian Regan - The Emergency Room https://youtu.be/d2Vg3iSd5ms See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Bears. Beets. COVID-19 Updates | GameChangers Mar 02, 2021

Show notes

The recently published (in a pre-print server) COLCORONA study, sponsored by the Montreal Heart institute and conducted in 6 countries aimed to show if using colchicine would decrease risk of hospitalization and death in outpatients with COVID-19. Will it work? How's the study design? Learn the facts. Reference: Tardif J, Bouabdallaoui N, L'Allier P, et al. Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19. Pre-Print. https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1 CPE details for GameChangers Podcast March 2021 Learning Objective: Apply the results of the CORCORONA study to patients with COVID-19 disease. 0107-0000-21-097-H01-P 0.25 CEU/2.5 Hrs (Knowledge) Initial Release Date: 03/02/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Related Podcasts